Martínez SC

Language: Spanish
References: 14
Page: 93-97
PDF size: 68.22 Kb.

ABSTRACT

The ever-increasing knowledge of the physiopathology involved in acute myocardial infarction (AMI) has allowed improving its treatment. We know now the protagonist role played by intracoronary thrombi in AMI development with ST elevation, which gave rise to the reperfusion concept; in the beginning treated pharmacologically (thrombolytic), followed by direct angioplasty, and at present with a combination of strategies, always emphasizing on the artery responsible for the infarct. Recently, the participation of the inflammatory process has been stressed in its physiopathology, which has widened the therapeutic approach, leading to consider necessarily whether in the acute event only one vessel is involved or the rest of the coronary vessels are being activated simultaneously, i.e., an “acute pan-coronary disease”. This, in turn, poses the following question: Should they all be treated? Or should one or several pharmacological measures be taken to inactivate the rest of the arteries and treat them afterwards, resolving only the occluded vessel in the realm of the AMI with ST elevation.

REFERENCES

1. Carrillo CJ, Chuquiure VE, Martínez Sánchez C: Análisis de la Permeabilidad por tombolisis de la Arteria Responsable del Infarto Miocardico Agudo. Arch Instit Cardiol Mex 1967; 67: 126-131.

2. Shah PK: Pathophysiology of coronary thrombosis: Role of plaque rupture and plaque erosion. Prog Cardiovasc Dis 2002; 44(5): 357-368.

3. Goldstein JA, Demetrion D, Grines CL, Pica Bi, Shoukfem M, O’Meill W: Multiple Complex Coronary plaques in patient with Acute Myocardial Infarction. N Engl J Med 200; 343(3): 0915-922.

4. Asakura M, Veda Y, Yamaguchi O, Adachi T, Hirayama A, Hori M, Kodama K: Extensive development of Vulnerable plaques as a PAN-Coronary process in Patient with myocardial infartion: An Angioscopic Study. J Am Col Cardiol 2001; 37(5): 1284-1288.

5. Virmani R, Burkie A, Farb A, Kolodgie F: Pathology of the Unstable plaque. Prog Cardiovasc Dis 2002; 44(5): 349-356.

6. Monroe VS, Parilak L, Kerensly R: Angiographic Patterns and the Natural History of the vulnerable plaque. Prog Cardiovasc Dis 2002; 44 (5): 339-347.

7. Ruberg F, Leopold S, Loscalzo J: Atherothrombosis Plaque Instability and Thrombo Genesis. Prog Cardiovasc Dis 2002; 44: 381-394.

8. Buffon A, Biasucci L, Liuzzo G, D’Onfrio G, Crea F, Maseri A: Coronary Inflammation in Unstable Angina. N Engl J Med 2002; 347(1): 5-12.

9. Biauscci L, Lluzzo G, Grillo RL: Elevated levels of C-Reactive Protein at Discharge in Patient With Unstable Angina Paedict Recurrent Instability. Circulation 1999; 99: 855-860.

10. Antman EM, Tana Siejevic MC, Thomson B: Cardiac Specific Troponin I. Levels To Predict the risk of mortality in patient with Acute Coronary Syndromes. N Engl J Med 1996; 335: 1342-1399.

11. Ambrose JA, Martinez EE: A New Paradigm for Plaque Stabilization. Circulation 2002; 150: 2000-2004.

12. Lupi HE, González H, Juárez U, Chuquiure E, Vieyra G, Martínez Sánchez C: La meta de la reperfusión en los Síndromes Isquémicos Coronarios Agudos con elevación del segmento ST. El gran Paradigma “Lo que hay más allá del Flujo TIMI3 Epicárdico. El TIMI4 Miocárdico”. Arch Cardiol Méx 2002; 72: 311-349.

13. Altman R, Luciardi HL, Muntaner J, Del Rio F, Berman SG, López R, González C: Efficacy Assessment of Meloxicam, a preferential Cyclooxygenase-2 Inhibitor, in Acute Coronary Syndromes Without ST-Segment Elevation. The Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 ( NUT-2) Pilot Study. Circulation 2002; 106: 191-195.

14. Martínez Sánchez C: Reperfusión Farmacológica en el infarto Agudo del Miocardio. Arch Cardiol Mex 2001; 71(Supl.): S131-S135.